HomeRKV • CVE
add
Rakovina Therapeutics Inc
Previous close
$0.050
Day range
$0.045 - $0.065
Year range
$0.040 - $0.23
Market cap
8.43M CAD
Avg Volume
373.38K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.39M | 110.87% |
Net income | -1.48M | -105.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.26M | -139.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.31M | 200.87% |
Total assets | 6.24M | 21.24% |
Total liabilities | 1.94M | 30.53% |
Total equity | 4.30M | — |
Shares outstanding | 100.22M | — |
Price to book | 1.25 | — |
Return on assets | -60.39% | — |
Return on capital | -68.45% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.48M | -105.32% |
Cash from operations | -1.76M | -366.74% |
Cash from investing | — | — |
Cash from financing | 2.82M | 281,738,200.00% |
Net change in cash | 1.06M | 380.54% |
Free cash flow | -1.17M | -707.31% |
About
Founded
2019
Headquarters
Website
